Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.98
Hoth Therapeutics, Inc. issued 2,857,144 shares of its common stock (or common stock equivalents in lieu thereof) of common stock for $0.70 per share.
- Security
- common stock
- Shares
- 2,857,144 shares of its common stock (or common stock equivalents in lieu thereof)
- Consideration
- $0.70 per share
Exact text from the filing
Hoth Therapeutics Announces Closing of $2.0 Million Registered Direct Offering NEW YORK, April 2, 2026 – Hoth Therapeutics, Inc. (Nasdaq: HOTH), a clinical-stage biopharmaceutical company focused on developing innovative therapies for unmet medical needs, today announced the closing of its previously announced registered direct offering for the purchase and sale of an aggregate of 2,857,144 shares of its common stock (or common stock equivalents in lieu thereof) at an offering price of $0.70 per share of common stock (or per common stock equivalent in lieu thereof).
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.98
Hoth Therapeutics, Inc. issued warrants to purchase up to an aggregate of 2,857,144 shares of common stock of warrant.
- Security
- warrant
- Shares
- warrants to purchase up to an aggregate of 2,857,144 shares of common stock
Exact text from the filing
Additionally, in a concurrent private placement, the Company issued and sold unregistered warrants to purchase up to an aggregate of 2,857,144 shares of common stock at an exercise price of $0.85 per share.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Hoth Therapeutics, Inc. entered into Securities Purchase Agreement with certain institutional investors valued at Company agreed to sell 2,857,144 shares of common stock at $0.70 per share; gross proceeds approxima (effective 2026-04-01).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- certain institutional investors
- Value
- Company agreed to sell 2,857,144 shares of common stock at $0.70 per share; gross proceeds approxima
- Effective
- 2026-04-01
Exact text from the filing
On April 1, 2026, Hoth Therapeutics, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with certain institutional investors, pursuant to which the Company agreed to sell to such investors 2,857,144 shares (the “Shares”) of common stock of the Company (the “Common Stock”), at a purchase price of $0.70 per share of Common Stock (the “Offering”).
View on SEC.gov